Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Muscle Relaxant Drugs Market, by Drug Type
1.4.2 Europe Muscle Relaxant Drugs Market, by Route of Administration
1.4.3 Europe Muscle Relaxant Drugs Market, by Distribution Channel
1.4.4 Europe Muscle Relaxant Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Muscle Relaxant Drugs Market by Drug Type
3.1 Europe Skeletal Market by Country
3.2 Europe Neuromuscular Blocking Agents Market by Country
3.3 Europe Facial Muscle Relaxant Drugs Market by Country
Chapter 4. Europe Muscle Relaxant Drugs Market by Route of Administration
4.1 Europe Oral Market by Country
4.2 Europe Injectable Market by Country
Chapter 5. Europe Muscle Relaxant Drugs Market by Distribution Channel
5.1 Europe Hospital Pharmacy Market by Country
5.2 Europe Retail Pharmacy Market by Country
5.3 Europe Online Pharmacies Market by Country
Chapter 6. Europe Muscle Relaxant Drugs Market by Country
6.1 Germany Muscle Relaxant Drugs Market
6.1.1 Germany Muscle Relaxant Drugs Market by Drug Type
6.1.2 Germany Muscle Relaxant Drugs Market by Route of Administration
6.1.3 Germany Muscle Relaxant Drugs Market by Distribution Channel
6.2 UK Muscle Relaxant Drugs Market
6.2.1 UK Muscle Relaxant Drugs Market by Drug Type
6.2.2 UK Muscle Relaxant Drugs Market by Route of Administration
6.2.3 UK Muscle Relaxant Drugs Market by Distribution Channel
6.3 France Muscle Relaxant Drugs Market
6.3.1 France Muscle Relaxant Drugs Market by Drug Type
6.3.2 France Muscle Relaxant Drugs Market by Route of Administration
6.3.3 France Muscle Relaxant Drugs Market by Distribution Channel
6.4 Russia Muscle Relaxant Drugs Market
6.4.1 Russia Muscle Relaxant Drugs Market by Drug Type
6.4.2 Russia Muscle Relaxant Drugs Market by Route of Administration
6.4.3 Russia Muscle Relaxant Drugs Market by Distribution Channel
6.5 Spain Muscle Relaxant Drugs Market
6.5.1 Spain Muscle Relaxant Drugs Market by Drug Type
6.5.2 Spain Muscle Relaxant Drugs Market by Route of Administration
6.5.3 Spain Muscle Relaxant Drugs Market by Distribution Channel
6.6 Italy Muscle Relaxant Drugs Market
6.6.1 Italy Muscle Relaxant Drugs Market by Drug Type
6.6.2 Italy Muscle Relaxant Drugs Market by Route of Administration
6.6.3 Italy Muscle Relaxant Drugs Market by Distribution Channel
6.7 Rest of Europe Muscle Relaxant Drugs Market
6.7.1 Rest of Europe Muscle Relaxant Drugs Market by Drug Type
6.7.2 Rest of Europe Muscle Relaxant Drugs Market by Route of Administration
6.7.3 Rest of Europe Muscle Relaxant Drugs Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Amneal Pharmaceuticals, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisition and Mergers:
7.2 Ipsen Pharma Biotech SAS
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.3 Merz Pharma GmbH & Co. KGaA
7.3.1 Company Overview
7.4 Mallinckrodt PLC
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Eisai Co., Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Endo International PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental Analysis
7.7.4 Research & Development Expense
7.8 Vertical Pharmaceuticals, LLC
7.8.1 Company Overview
7.9 SteriMax Inc.
7.9.1 Company Overview
7.10. Metacel Pharmaceuticals, LLC.
7.10.1 Company Overview